SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-021412
Filing Date
2023-08-01
Accepted
2023-08-01 16:21:10
Documents
13
Period of Report
2023-09-07

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A urgn20230411_def14a.htm DEF 14A 981236
2 c01.jpg GRAPHIC 124718
3 c02.jpg GRAPHIC 65181
4 c03.jpg GRAPHIC 50647
5 c04.jpg GRAPHIC 55691
6 lbsignature.jpg GRAPHIC 3218
7 proxycardfinal08012023pg1of2.jpg GRAPHIC 101464
8 proxycardfinalpg2of2.jpg GRAPHIC 86096
9 urogen01.jpg GRAPHIC 9078
10 urogen03.jpg GRAPHIC 32218
11 urogen04.jpg GRAPHIC 5929
12 urogen05.jpg GRAPHIC 5643
13 urogen06.jpg GRAPHIC 5362
  Complete submission text file 0001437749-23-021412.txt   1723550
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 231132023
SIC: 2834 Pharmaceutical Preparations